Home LiteratureArticle Details
PMID: 3872844 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.

Infection and immunity ·Vol. 48 ·No. 2 ·1985-05-00 ·Pages 343-9

Toews GB, Hart DA, Hansen EJ

Abstract

The effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b (Hib) was studied in a mouse model system. Immunization of mice by intraperitoneal injection of viable Hib cells resulted in the appearance of Hib-directed antibodies in both serum and bronchoalveolar lavage fluid. The development of this Hib-directed antibody activity was associated with significant enhancement of early pulmonary clearance of Hib. Systemic immunization did not affect the recruitment of polymorphonuclear leukocytes to the alveoli, suggesting that the enhanced clearance of Hib observed in immunized animals was due to specific antibodies which promote either phagocytosis or extracellular killing of Hib. The spectrum of Hib-directed antibody specificities detected in sera from immunized animals was essentially identical to that detected in bronchoalveolar lavage fluids from these same animals. Similarly, intravenous administration of an immunoglobulin G monoclonal antibody specific for Hib lipopolysaccharide resulted in the subsequent appearance of this antibody in the alveolar spaces where it enhanced pulmonary clearance of Hib. This study shows that this mouse model system can be used to measure the effect of both active and passive immunization on the clearance of Hib from the lower respiratory tract.

MeSH Terms
Animals Antibodies, Bacterial/analysis,immunology Antibodies, Monoclonal/immunology Cell Count Haemophilus Infections/immunology Haemophilus influenzae/immunology Immunization Immunization, Passive Lipopolysaccharides/immunology Lung/immunology Mice Mice, Inbred BALB C Neutrophils/immunology Phagocytes/immunology Pneumonia/immunology Pulmonary Alveoli/immunology
Chemicals
Antibodies, Bacterial Antibodies, Monoclonal Lipopolysaccharides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Toews G B
Hart D A
Hansen E J
References (36)
36 references, click to expand
  1. A set of two monoclonal antibodies specific for the cell surface-exposed 39K major outer membrane protein of Haemophilus influenzae type b defines all strains of this pathogen.
    Infect Immun. 1983 Nov;42(2):516-24 PMID: 6605924
  2. Acute respiratory infections in children. A global public-health problem.
    N Engl J Med. 1984 Apr 12;310(15):982-4 PMID: 6700693
  3. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae.
    Am Rev Respir Dis. 1984 Jan;129(1):82-6 PMID: 6703488
  4. Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment.
    J Infect Dis. 1984 May;149(5):728-34 PMID: 6610002
  5. Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.
    Infect Immun. 1984 Jul;45(1):36-40 PMID: 6610640
  6. Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.
    Infect Immun. 1984 Aug;45(2):437-42 PMID: 6611311
  7. Characterization of the extracellular bactericidal factors of rat alveolar lining material.
    J Clin Invest. 1984 Oct;74(4):1269-79 PMID: 6548228
  8. THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.
    J Exp Med. 1964 Jan 1;119:167-76 PMID: 14113111
  9. Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.
    J Immunol. 1973 Aug;111(2):358-68 PMID: 4197982
  10. Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages.
    J Immunol. 1973 Aug;111(2):369-80 PMID: 4197983
  11. Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.
    Am Rev Respir Dis. 1973 Oct;108(4):784-90 PMID: 4582433
  12. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.
    J Clin Invest. 1974 Sep;54(3):519-28 PMID: 4853956
  13. Expression of immune mechanisms in the lung.
    Am Rev Respir Dis. 1976 Mar;113(3):347-79 PMID: 769616
  14. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material.
    J Clin Invest. 1976 Aug;58(2):271-5 PMID: 956366
  15. Lung defense mechanisms (second of two parts).
    N Engl J Med. 1976 Nov 4;295(19):1045-52 PMID: 787791
  16. Bacteremic hemophilus influenzae pneumonia in adults. A report of 24 cases and a review of the literature.
    Am J Med. 1977 Feb;62(2):219-24 PMID: 835601
  17. Defense mechanisms of the respiratory membrane.
    Am Rev Respir Dis. 1977 Mar;115(3):479-514 PMID: 320925
  18. Hemophilus influenzae pneumonia in adults.
    Am J Med. 1978 Jan;64(1):87-93 PMID: 304671
  19. The effect of complement depletion on lung clearance of bacteria.
    J Clin Invest. 1978 Aug;62(2):373-8 PMID: 27534
  20. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae.
    J Infect Dis. 1978 Oct;138(4):427-36 PMID: 309494
  21. Haemophilus influenzae infections in adults: report of nine cases and a review of the literature.
    Medicine (Baltimore). 1979 Jan;58(1):80-94 PMID: 310943
  22. The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice.
    Am Rev Respir Dis. 1979 Sep;120(3):559-66 PMID: 114074
  23. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  24. Immune stimulation of lung bactericidal activity: evidence for both cellular and humoral participation after immunization with Serratia marcescens.
    Am Rev Respir Dis. 1980 Jun;121(6):921-9 PMID: 6998336
  25. Heightened lung bactericidal activity in mice after aerosol immunization with Re 595 Salmonella minnesota: importance of cellular rather than humoral factors.
    J Infect Dis. 1980 Sep;142(3):421-31 PMID: 7003033
  26. Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system.
    Infect Immun. 1981 Jun;32(3):1084-92 PMID: 6972915
  27. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    J Immunol. 1982 Apr;128(4):1772-5 PMID: 6977569
  28. Nontypeable Haemophilus influenzae in the elderly.
    Arch Intern Med. 1982 Mar;142(3):537-9 PMID: 6978116
  29. A dot-immunobinding assay for monoclonal and other antibodies.
    Anal Biochem. 1982 Jan 1;119(1):142-7 PMID: 7072935
  30. Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b.
    Infect Immun. 1982 Apr;36(1):80-8 PMID: 6176548
  31. Mechanisms of complement-mediated clearance of bacteria from the murine lung.
    Am Rev Respir Dis. 1982 May;125(5):517-20 PMID: 7081809
  32. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.
    Infect Immun. 1982 Jul;37(1):82-8 PMID: 6980838
  33. Cefuroxime therapy for pneumonia in infants and children.
    Pediatr Infect Dis. 1982 May-Jun;1(3):159-63 PMID: 6755404
  34. Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus.
    Am Rev Respir Dis. 1983 Mar;127(3):335-41 PMID: 6830054
  35. Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae.
    J Infect Dis. 1983 Sep;148(3):492-9 PMID: 6604761
  36. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae.
    Ann Intern Med. 1983 Oct;99(4):444-50 PMID: 6605104
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1985-05-00
Pages
343-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC261311
Subset
IM
Grants
NIAID NIH HHS · AI-17621 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]